Ross Lawrenson

ORCID: 0000-0003-0437-8839
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Global Cancer Incidence and Screening
  • Colorectal Cancer Screening and Detection
  • Global Health Workforce Issues
  • Breast Cancer Treatment Studies
  • Primary Care and Health Outcomes
  • Cancer Risks and Factors
  • Diabetes Management and Education
  • Lung Cancer Diagnosis and Treatment
  • Health disparities and outcomes
  • Reproductive Health and Contraception
  • Obesity and Health Practices
  • Lung Cancer Treatments and Mutations
  • Chronic Disease Management Strategies
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Prostate Cancer Diagnosis and Treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Diabetes Management and Research
  • Prostate Cancer Treatment and Research
  • Diabetes Treatment and Management
  • Healthcare Policy and Management
  • Venous Thromboembolism Diagnosis and Management
  • Economic and Financial Impacts of Cancer
  • Metabolism, Diabetes, and Cancer
  • Patient-Provider Communication in Healthcare
  • Cervical Cancer and HPV Research

University of Waikato
2016-2025

Waikato District Health Board
2011-2024

University of Otago
2006-2024

Waikato Regional Council
2023-2024

University of Auckland
2010-2023

Waikato Hospital
2008-2023

Clinical Trials New Zealand
2010-2023

May Institute
2021

Auckland University of Technology
2021

Michigan State University
2019

OBJECTIVE—To estimate the absolute and relative risk of cardiovascular disease (CVD) in patients with type 1 diabetes U.K. RESEARCH DESIGN AND METHODS—Subjects (n = 7,479) five age- sex-matched subjects without 38,116) free CVD at baseline were selected from General Practice Research Database (GPRD), a large primary care database representative population. Incident major events, comprising myocardial infarction, acute coronary heart death, revascularizations, or stroke, captured for period...

10.2337/diacare.29.04.06.dc05-1433 article EN Diabetes Care 2006-04-01

Abstract Aims Under‐reporting of diabetes on death certificates contributes to the unreliable estimates mortality as a result diabetes. The influence obesity in Type 2 is not well documented. We aimed study from and large cohort selected General Practice Research Database (GPRD). Methods A 44 230 patients aged 35–89 years 1992 with was identified. comparison group matched by year birth sex no record at any time identified (219 797). Hazards ratios (HRs) for all‐cause during period January...

10.1111/j.1464-5491.2006.01838.x article EN Diabetic Medicine 2006-04-20

Aim To describe the first specifically designed and validated five-level rurality classification for health purposes in New Zealand that is both data-driven incorporates heuristic understandings of rurality.

10.26635/6965.5495 article EN other-oa New Zealand medical journal 2022-08-05

Previous research identified inequities in all-cause mortality between Māori and non-Māori populations. Unlike comparable jurisdictions, rates rural areas have not been shown to be higher than those urban for either population. This paper uses contemporary data examine areas.A population-level observational study using deidentified routinely collected mortality, amenable census data. For each level of the Geographic Classification Health (GCH), age-sex standardised incident rates,...

10.1016/j.lanwpc.2022.100570 article EN cc-by-nc-nd The Lancet Regional Health - Western Pacific 2022-08-18

Aims The study was conducted to determine whether the method for selecting cases of venous thromboembolism (VTE) from general practice databases significantly affected findings an epidemiological study. Methods Cases VTE were identified UK General Practice Research Database (GPRD) by searching codes deep vein thrombosis (DVT) and pulmonary embolism (PE). These had be supported evidence anticoagulation exposed a combined oral contraceptive (COC) at time event. Additional information about...

10.1046/j.1365-2125.2000.00199.x article EN British Journal of Clinical Pharmacology 2000-06-01

People with multiple sclerosis, paraplegia and neural tube defects typically have neurogenic lower urinary tract dysfunction (NLUTD). This encompasses detrusor hyperreflexia or without sphincter dyssynergia hypo- acontractility. Their effects undermine safe, effective controlled storage voiding of urine predispose to reflux nephropathy. Therefore, patients in these diagnostic groups NLUTD would be expected increased risk renal failure. The aim this study was quantify using the General...

10.1159/000054774 article EN Neuroepidemiology 2001-01-01

Aims In October 1995 in response to the results of three studies, Committee on Safety Medicines advised doctors and pharmacists that oral contraceptives containing desogestrel (DSG) gestodene (GST) were associated with around a two‐fold increase risk thromboembolism compared those other progestogens. The objective this study was estimate idiopathic venous thromboembolic disease (VTE) users combined (COCs), compare between formulations examine effect using age banding as opposed matching by...

10.1046/j.1365-2125.2000.00198.x article EN British Journal of Clinical Pharmacology 2000-06-01

In all countries people experience different social circumstances that result in avoidable differences health. New Zealand, Māori, Pacific peoples, and those with lower socioeconomic status higher levels of chronic illness, which is the leading cause mortality, morbidity inequitable health outcomes. Whilst system can enable a fairer distribution good health, limited national data available to measure equity. Therefore, we sought find out whether services Zealand were equitable by measuring...

10.1186/1475-9276-10-45 article EN cc-by International Journal for Equity in Health 2011-01-01

Androgen deprivation therapy (ADT) administered as a prostate cancer treatment is known to exert multiple side effects including bone deterioration leading fracture. The current analysis evaluate the burden of fracture risk in New Zealand (PCa) population treated with ADT, and understand subsequent mortality after Using datasets created through linking records from Cancer Registry, National Minimal Dataset, Pharmaceutical Collection Mortality Collection, we studied 25,544 men (aged ≥40...

10.1186/s12885-015-1843-3 article EN cc-by BMC Cancer 2015-11-02

New Zealand has major ethnic disparities in breast cancer survival with Māori (indigenous people) and Pacific women (immigrants or descended from immigrants Islands) faring much worse than other groups. This paper identified underlying factors assessed their relative contribution to this risk differential. study involved all who were diagnosed primary invasive two health regions, covering about 40% of the national population, between January 2000 June 2014. patients compared groups terms...

10.1186/s12885-017-3797-0 article EN cc-by BMC Cancer 2018-01-08

Examination of factors associated with late stage diagnosis breast cancer is useful to identify areas which are amenable intervention. This study analyses trends in at and impact socio-demographic, biological screening characteristics on a population-based series women invasive New Zealand.All diagnosed between 2000 2013 were identified from two regional registries. Factors advanced (stages III IV) metastatic (stage analysed univariate multivariate models adjusting for covariates.Of the...

10.1186/s12885-016-2177-5 article EN cc-by BMC Cancer 2016-02-19

Statins are the most widely prescribed cholesterol lowering medications and have been associated with both improved unchanged breast cancer outcomes in previous studies. This study examines association between post-diagnostic use of statins (death recurrence) a large, representative sample New Zealand (NZ) women cancer.Women diagnosed first primary 2007 2016 were identified from four population-based regional NZ registries linked to national pharmaceutical data, hospital discharges, death...

10.1007/s10549-022-06815-w article EN cc-by Breast Cancer Research and Treatment 2023-03-17

Objectives Examine the impact of two generic—urban–rural experimental profile (UREP) and urban accessibility (UA)—and one purposely built—geographic classification for health (GCH)—rurality systems on identification rural–urban disparities in Aotearoa New Zealand (NZ). Design A comparative observational study. Setting NZ; most recent 5 years available data mortality events (2013–2017), hospitalisations non-admitted hospital patient (both 2015–2019). Participants Numerator included deaths (n...

10.1136/bmjopen-2022-067927 article EN cc-by-nc BMJ Open 2023-04-01

Indigenous Māori women experience a 60% higher breast cancer mortality rate compared with European in New Zealand. We explored the impact of differences rates screen detected on inequities stage at diagnosis and survival between NZ women.All primary cancers diagnosed screening age (as defined by Zealand National Breast Cancer Screening Programme) during 1999-2012 Waikato area (n = 1846) were identified from Register Database. Stage for 1106) non-screen 740) ethnicity socioeconomic...

10.1186/s12889-015-1383-4 article EN cc-by BMC Public Health 2015-01-30

Māori in Aotearoa have higher incidence, prevalence and mortality from chronic disease. The dominant narrative about the reasons for ill health neglects to acknowledge history of colonisation failures system, alongside holistic view taken by focusing on collective, whānau-based outcomes. In this article, we review interventions disease that a kaupapa philosophical basis. Our findings demonstrate there is no clear process service design, delivery, research funding values understands...

10.1177/1177180120919166 article EN AlterNative An International Journal of Indigenous Peoples 2020-05-25
Coming Soon ...